Assessing Moral Cognitive Skills in Adults With Autism Spectrum Disorders
NCT ID: NCT05551260
Last Updated: 2024-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2023-05-02
2025-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Investigators planned to study how people with ASD without intellectual disability process emotions expressed by others in response to different forms of moral offense and to examine whether patterns potentially contrast in degree and/or kind with those of neurotypicals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuropsychomotor Functions in Children With Autism Spectrum Disorder
NCT01987037
Use of a Smartphone© Application to Study Autism Spectrum Disorders (ASD)
NCT03020277
Efficiency of Early Intervention for Autism Spectrum Disorder
NCT02608333
Telepsychiatry in Children: Diagnostic Evaluation of Autism Spectrum Disorder
NCT06622395
Cognitive Neuroscience of Autism Spectrum Disorders
NCT01031407
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The theoretical hypotheses of the CoMorA project are the following:
* In the explicit response condition, people with ASD will show different emotional assignment patterns than controls do, depending on the nature of the offense (accidental transgression, attempted harm, and intentional harm).
* In the implicit response condition, people with ASD will exhibit emotion processing patterns identical to those of controls.
* The differences in responses of controls and people with ASD in the explicit condition will be underpinned by executive functions and social cognitive performances.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
People with ASD
30 people with ASD without IDD
Neuropsychological assessments (tests allowing to measures attentional, executive and emotional performances) and experimental protocol assessing moral cognition
Day 0: sending of the information notice
Day 1 : signing the consent form + neuropsychological tests assessing reasoning and abstraction abilities, attentional processes, executive functions (including inhibition and mental flexibility) and social cognitive functions, including facial emotion recognition, theory of mind and perception and social knowledge (duration 1h30-2h). Experimental protocol: vignettes of moral offenses manipulating variables of intention and consequence. This systematic manipulation, commonly used in the field of moral judgment, usually leads to 3 combinations of variables: intentional harm (present intention; present consequence); attempted harm (intent present; consequence absent); accidental harm (intention absent; consequence present). Another form of accidental harm will also be constructed (positive intention; present consequence) (duration : 1h)
Between day 1 and day 21 : second part of the Day 1 tests
Neurotypicals
30 neurotypicals
Neuropsychological assessments (tests allowing to measures attentional, executive and emotional performances) and experimental protocol assessing moral cognition
Day 0: sending of the information notice
Day 1 : signing the consent form + neuropsychological tests assessing reasoning and abstraction abilities, attentional processes, executive functions (including inhibition and mental flexibility) and social cognitive functions, including facial emotion recognition, theory of mind and perception and social knowledge (duration 1h30-2h). Experimental protocol: vignettes of moral offenses manipulating variables of intention and consequence. This systematic manipulation, commonly used in the field of moral judgment, usually leads to 3 combinations of variables: intentional harm (present intention; present consequence); attempted harm (intent present; consequence absent); accidental harm (intention absent; consequence present). Another form of accidental harm will also be constructed (positive intention; present consequence) (duration : 1h)
Between day 1 and day 21 : second part of the Day 1 tests
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuropsychological assessments (tests allowing to measures attentional, executive and emotional performances) and experimental protocol assessing moral cognition
Day 0: sending of the information notice
Day 1 : signing the consent form + neuropsychological tests assessing reasoning and abstraction abilities, attentional processes, executive functions (including inhibition and mental flexibility) and social cognitive functions, including facial emotion recognition, theory of mind and perception and social knowledge (duration 1h30-2h). Experimental protocol: vignettes of moral offenses manipulating variables of intention and consequence. This systematic manipulation, commonly used in the field of moral judgment, usually leads to 3 combinations of variables: intentional harm (present intention; present consequence); attempted harm (intent present; consequence absent); accidental harm (intention absent; consequence present). Another form of accidental harm will also be constructed (positive intention; present consequence) (duration : 1h)
Between day 1 and day 21 : second part of the Day 1 tests
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of ASD according to DSM-5 criteria
* Age between 18 and 40 years old
* Francophone
* Affiliated to social security
* Having given their consent to participate in the study
* Patient under guardianship and curatorship
Neurotypical group:
* Age between 18 and 40 years old
* Francophone
* Affiliated to a social security scheme
* Having given their consent to participate in the study
Exclusion Criteria
* Diagnosis of intellectual development disorder established according to DSM-5 criteria
* Language, sensory or motor impairments hindering participation in the study
Control group:
* Neurodevelopmental pathology (declarative)
* Neurological pathology
* Language, sensory or motor impairments hindering participation in the study
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital le Vinatier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elodie PEYROUX
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier le Vinatier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
centre de réhabilitation - Hôpital le Vinatier
Lyon, Rhône, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A01040-43
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.